Management of thromboembolic risk in persons with haemophilia and atrial fibrillation: Is left atrial appendage occlusion the answer for those at high risk?

Haemophilia

Volumn 19, Issue 2, 2013, Pages

  Cheung, V T F ^a,b   Hunter, R J ^a,b   Ginks, M R ^a,b   Schilling, R J ^a,b   Earley, M J ^a,b   Bowles, L ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Appendage occlusion; Atrial fibrillation; Haemophilia; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; RECOMBINANT BLOOD CLOTTING FACTOR 8; WARFARIN;

CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEMOPHILIA; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; ISCHEMIC HEART DISEASE; LETTER; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT DURATION;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; HEMOPHILIA A; HUMANS; MALE; RISK FACTORS; THERAPEUTIC OCCLUSION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84874117937     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12055     Document Type: Letter

References (10)

1. Darby SC, Kan SW, Spooner RJ et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-25. Epub 2007 Apr 19.
2. Kulkarni R, Soucie JM, Evatt BL. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005; 79: 36-42.
3. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-70.
4. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
5. Cid AR, Zorio E, Haya S et al. Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease. Haemophilia 2007; 13: 760-2.
6. Mannucci PM, Mauser-Bunschoten EP. Cardiovascular disease in haemophilia patients: a contemporary issue. Haemophilia 2010; 16(Suppl. 3): 58-66.
7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-67.
8. Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009; 374: 534-42.
9. Meier B, Palacios I, Windecker S et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60: 417-22.
10. Ostermayer SH, Reisman M, Kramer PH et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am CollCardiol 2005; 46: 9-14.